China Medicine CHME · USD

Its shares trade under the ticker CHME. It has been listed since 23 June 2005.

China Medicine Corp. engages in the development, manufacture, and sale of western pharmaceuticals, traditional Chinese medicines, and other healthcare products. The company is headquartered in Guangzhou, Guangdong. The company went IPO on 2005-06-23. The firm is engaged in the production and distribution of prescription and over the counter (OTC) drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The firm is developing a number of products for a range of indications, including oncology, high blood pressure and the removal of toxins from food and animal feeds. The firm's products include Shuangdan Capsules, Houerhuan Anti-inflammatory Capsules, Shugan Yipi Granules, Danggui Tiaojing Granules, Huangzao Granules, Pingfeng Shengmai Capsules, Danqi Tablets and Naodesheng Tablets. The firm also offers a range of dietary supplements, which include BeThin Tablets, Refrelizer Herbal Tea, LifeFull Herbal Tea and Relaxetox Herbal Tea. Shuangdan Capsules are indicated for the treatment of stagnation of the heart blood, obstruction of qi in the chest and cardiodynia.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Senshan YangChief Executive Officer, Director, since 2006$289,594
• Chi Fung HoChief Financial Officer, Vice President - Finance and Accounting
• Ms. Minhua LiuExecutive Vice President, since 2006$258,945
• Ms. Rachel GongIndependent Director
• Mr. Ian RobinsonIndependent Director
• Mr. Ryan ShihIndependent Director

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.